Epizyme (EPZM) and Kamada (KMDA), the only IPOs to be completed in a relatively quiet week, pushed the US IPO market into new post-recession territory on Friday. The two deals were the 29th and 30th of the month, making May the first month with ...read more
Kamada, which provides plasma-derived protein therapeutics mostly in Israel and the US, raised $52 million by offering 5.6 million shares at $9.25. Kamada plans to list on the NASDAQ under the symbol KMDA. Kamada initially filed confidentially on 1/24/2013....read more
Exactly one year after Facebook priced its ill-fated IPO, two fast-growing technology companies, Marketo (MKTO) and Tableau (DATA), surged on their first days of trading. Marketo, a marketing software company, jumped 78% on Friday in the best first-day...read more
US IPO Recap: May ends with 30 pricings, two billion-dollar deals set for June
Epizyme (EPZM) and Kamada (KMDA), the only IPOs to be completed in a relatively quiet week, pushed the US IPO market into new post-recession territory on Friday. The two deals were the 29th and 30th of the month, making May the first month with ...read more
Kamada prices IPO at $9.25, raising $52 million
Kamada, which provides plasma-derived protein therapeutics mostly in Israel and the US, raised $52 million by offering 5.6 million shares at $9.25. Kamada plans to list on the NASDAQ under the symbol KMDA. Kamada initially filed confidentially on 1/24/2013....read more
2 US IPOs planned for the week of May 27
The following IPOs are expected to price this week: Epizyme (EPZM), a biotech developing therapeutics for patients with genetically defined cancers, plans to raise $60...read more
US IPO Recap: Marketo and Tableau soar, May calendar stays full
Exactly one year after Facebook priced its ill-fated IPO, two fast-growing technology companies, Marketo (MKTO) and Tableau (DATA), surged on their first days of trading. Marketo, a marketing software company, jumped 78% on Friday in the best first-day...read more